Ikuo Ogihara
Director/Board Member at ActivX Biosciences, Inc.
Profile
Ikuo Ogihara is President and Chief Executive Officer of Kyorin Pharmaceutical Co. Ltd.
He joined the company in 1980.
Currently, Mr. Ogihara is a Director of ActivX Biosciences, Inc. Previously, he was Executive Vice President, Senior Managing Director, Senior Executive Director and Executive Director of Kyorin.
Mr. Ogihara received an undergraduate degree from Meiji University.
Ikuo Ogihara active positions
| Companies | Position | Start |
|---|---|---|
ActivX Biosciences, Inc.
 ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology ActivX Biosciences, Inc. develops pharmaceutical products. It discovers and develops small molecule drugs for major unmet medical needs. The company was founded in 2000 and is located in La Jolla, CA | Director/Board Member | - |
Former positions of Ikuo Ogihara
| Companies | Position | End |
|---|---|---|
KYORIN Pharmaceutical Co. Ltd. (old)
 KYORIN Pharmaceutical Co. Ltd. (old) Pharmaceuticals: MajorHealth Technology KYORIN Pharmaceutical Co., Ltd. develops and supplies prescription medicines. Its primary drugs include antibacterial tablets, asthma tablets, gastric ulcer agents and mucoregulants. The company was founded in 1923 and is headquartered in Tokyo, Japan. | President | - |
Training of Ikuo Ogihara
| Meiji University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
ActivX Biosciences, Inc.
ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology ActivX Biosciences, Inc. develops pharmaceutical products. It discovers and develops small molecule drugs for major unmet medical needs. The company was founded in 2000 and is located in La Jolla, CA | Health Technology |
KYORIN Pharmaceutical Co. Ltd. (old)
KYORIN Pharmaceutical Co. Ltd. (old) Pharmaceuticals: MajorHealth Technology KYORIN Pharmaceutical Co., Ltd. develops and supplies prescription medicines. Its primary drugs include antibacterial tablets, asthma tablets, gastric ulcer agents and mucoregulants. The company was founded in 1923 and is headquartered in Tokyo, Japan. | Health Technology |
- Stock Market
- Insiders
- Ikuo Ogihara
